Clearance Summary
AccuPoint Electrode received FDA 510(k) clearance under submission number K162459, sponsored by Microprobes For Life Science, Inc. Dba Neuron. The device was reviewed via the Traditional premarket notification pathway and assigned to the Neurology review panel. The statutory decision date of record is 2017-06-15.
- Submission: K162459
- Applicant / Sponsor: Microprobes For Life Science, Inc. Dba Neuron
- Clearance pathway: Traditional
- Review panel: Neurology
- Device class: Class II
- Regulation citation: 21 CFR 882.1330
- Decision date: 2017-06-15
Classification & Regulation
This clearance is catalogued under FDA product code GZL and 21 CFR 882.1330, within the Neurology review panel as a Class II device.